Author Index

Search or browse for an author across our entire electronic archive

Search results for: M
Results 71 - 80 of 2577 shown below

  • M-Kähäri, V

    E Kerkelä, R Ala-aho, L Jeskanen, J Lohi, R Grénman, V M-Kähäri and U Saarialho-Kere

    Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers

    doi:10.1054/bjoc.2000.1634

    Abstract | Full article | PDF

  • Ma, D

    P K Julka, R T Chacko, S Nag, R Parshad, A Nair, D S Oh, Z Hu, C B Koppiker, S Nair, R Dawar, N Dhindsa, I D Miller, D Ma, B Lin, B Awasthy and C M Perou

    A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling

    advance online publication, 2008-04-01 00:00:00.000;

    doi:10.1038/sj.bjc.6604322

    Abstract | Full article | PDF

  • Ma, H

    K M Rieger-Christ, L Ng, R S Hanley, O Durrani, H Ma, A S Yee, J A Libertino and I C Summerhayes

    Restoration of plakoglobin expression in bladder carcinoma cell lines suppresses cell migration and tumorigenic potential

    advance online publication, 2005-06-07 00:00:00.000;

    doi:10.1038/sj.bjc.6602651

    Abstract | Full article | PDF

  • Y Lu, J Sullivan-Halley, W Cozen, E T Chang, K Henderson, H Ma, D Deapen, C Clarke, P Reynolds, S L Neuhausen, H Anton-Culver, G Ursin, D West and L Bernstein

    Family history of haematopoietic malignancies and non-Hodgkin's lymphoma risk in the California Teachers Study

    advance online publication, 2009-01-20 00:00:00.000;

    doi:10.1038/sj.bjc.6604881

    Abstract | Full article | PDF

  • Ma, I-F

    K-H Yeh, S-H Yeh, C-H Hsu, T-M Wang, I-F Ma and A-L Cheng

    Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil

    doi:10.1054/bjoc.2000.1456

    Abstract | Full article | PDF

  • Ma, J

    J H M Schellens, ASTh Planting, N van Zandwijk, J Ma, M Maliepaard, M E L van der Burg, M de Boer-Dennert, E Brouwer, A van der Gaast, M J van den Bent and J Verweij

    Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer

    doi:10.1038/sj.bjc.6600794

    Abstract | Full article | PDF

  • E S Schernhammer, G J Tranah, E Giovannucci, A T Chan, J Ma, G A Colditz, D J Hunter, W C Willett and C S Fuchs

    Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma

    advance online publication, 2006-02-21 00:00:00.000;

    doi:10.1038/sj.bjc.6603007

    Abstract | Full article | PDF

  • B M Wolpin, D S Michaud, E L Giovannucci, E S Schernhammer, M J Stampfer, J E Manson, B B Cochrane, T E Rohan, J Ma, M N Pollak and C S Fuchs

    Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts

    advance online publication, 2007-05-29 00:00:00.000;

    doi:10.1038/sj.bjc.6603826

    Abstract | Full article | PDF

  • U Tabori, V Wong, J Ma, M Shago, N Alon, J Rutka, E Bouffet, U Bartels, D Malkin and C Hawkins

    Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma

    advance online publication, 2008-09-16 00:00:00.000;

    doi:10.1038/sj.bjc.6604652

    Abstract | Full article | PDF

  • C Jesser, L Mucci, D Farmer, C Moon, H Li, J M Gaziano, M Stampfer, J Ma and P Kantoff

    Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels

    advance online publication, 2008-09-30 00:00:00.000;

    doi:10.1038/sj.bjc.6604690

    Abstract | Full article | PDF

  • Ma, M K

    P M Fracasso, K A Blum, M K Ma, B R Tan, L P Wright, S A Goodner, C L Fears, W Hou, M A Arquette, J Picus, A Denes, J E Mortimer, L Ratner, S P Ivy and H L McLeod

    Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar

    advance online publication, 2005-06-07 00:00:00.000;

    doi:10.1038/sj.bjc.6602653

    Abstract | Full article | PDF

  • Ma, N

    H Tanaka, N Fujita, R Sugimoto, N Urawa, S Horiike, Y Kobayashi, M Iwasa, N Ma, S Kawanishi, S Watanabe, M Kaito and Y Takei

    Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C

    advance online publication, 2008-01-29 00:00:00.000;

    doi:10.1038/sj.bjc.6604204

    Abstract | Full article | PDF

  • Ma, P C

    P C Ma, M S Tretiakova, V Nallasura, R Jagadeeswaran, A N Husain and R Salgia

    Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion

    advance online publication, 2007-07-31 00:00:00.000;

    doi:10.1038/sj.bjc.6603884

    Abstract | Full article | PDF

  • Z Tang, R Du, S Jiang, C Wu, D S Barkauskas, J Richey, J Molter, M Lam, C Flask, S Gerson, A Dowlati, L Liu, Z Lee, B Halmos, Y Wang, J A Kern and P C Ma

    Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer

    advance online publication, 2008-08-26 00:00:00.000;

    doi:10.1038/sj.bjc.6604559

    Abstract | Full article | PDF

  • Ma, Q

    Z Wang, Q Ma, Q Liu, H Yu, L Zhao, S Shen and J Yao

    Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway

    advance online publication, 2008-10-28 00:00:00.000;

    doi:10.1038/sj.bjc.6604745

    Abstract | Full article | PDF

  • Ma, S

    S Ma, S Egyházi, T Ueno, C Lindholm, E L Kreklau, U Stierner, U Ringborg and J Hansson

    O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma

    doi:10.1038/sj.bjc.6601270

    Abstract | Full article | PDF